KANK1
KN motif and ankyrin repeat domain-containing protein 1
Also known as: ANKRD15, KANK, KANK1_HUMAN, KIAA0172
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14678
- Gene
- KANK1
- Ensembl
- ENSG00000107104
- Chromosome
- 9
- Canonical length
- 1352 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
The protein encoded by this gene belongs to the Kank family of proteins, which contain multiple ankyrin repeat domains. This family member functions in cytoskeleton formation by regulating actin polymerization. This gene is a candidate tumor suppressor for renal cell carcinoma. Mutations in this gene cause cerebral palsy spastic quadriplegic type 2, a central nervous system development disorder. A t(5;9) translocation results in fusion of the platelet-derived growth factor receptor beta gene (PDGFRB) on chromosome 5 with this gene in a myeloproliferative neoplasm featuring severe thrombocythemia. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 20. [provided by RefSeq, Dec 2014]
Canonical amino-acid sequenceUniProt
1352 residues, UniProt reviewed canonical sequence.
>Q14678|KANK1
1 MAHTTKVNGS ASGKAGDILS GDQDKEQKDP YFVETPYGYQ LDLDFLKYVD DIQKGNTIKR
61 LNIQKRRKPS VPCPEPRTTS GQQGIWTSTE SLSSSNSDDN KQCPNFLIAR SQVTSTPISK
121 PPPPLETSLP FLTIPENRQL PPPSPQLPKH NLHVTKTLME TRRRLEQERA TMQMTPGEFR
181 RPRLASFGGM GTTSSLPSFV GSGNHNPAKH QLQNGYQGNG DYGSYAPAAP TTSSMGSSIR
241 HSPLSSGIST PVTNVSPMHL QHIREQMAIA LKRLKELEEQ VRTIPVLQVK ISVLQEEKRQ
301 LVSQLKNQRA ASQINVCGVR KRSYSAGNAS QLEQLSRARR SGGELYIDYE EEEMETVEQS
361 TQRIKEFRQL TADMQALEQK IQDSSCEASS ELRENGECRS VAVGAEENMN DIVVYHRGSR
421 SCKDAAVGTL VEMRNCGVSV TEAMLGVMTE ADKEIELQQQ TIESLKEKIY RLEVQLRETT
481 HDREMTKLKQ ELQAAGSRKK VDKATMAQPL VFSKVVEAVV QTRDQMVGSH MDLVDTCVGT
541 SVETNSVGIS CQPECKNKVV GPELPMNWWI VKERVEMHDR CAGRSVEMCD KSVSVEVSVC
601 ETGSNTEESV NDLTLLKTNL NLKEVRSIGC GDCSVDVTVC SPKECASRGV NTEAVSQVEA
661 AVMAVPRTAD QDTSTDLEQV HQFTNTETAT LIESCTNTCL STLDKQTSTQ TVETRTVAVG
721 EGRVKDINSS TKTRSIGVGT LLSGHSGFDR PSAVKTKESG VGQININDNY LVGLKMRTIA
781 CGPPQLTVGL TASRRSVGVG DDPVGESLEN PQPQAPLGMM TGLDHYIERI QKLLAEQQTL
841 LAENYSELAE AFGEPHSQMG SLNSQLISTL SSINSVMKSA STEELRNPDF QKTSLGKITG
901 NYLGYTCKCG GLQSGSPLSS QTSQPEQEVG TSEGKPISSL DAFPTQEGTL SPVNLTDDQI
961 AAGLYACTNN ESTLKSIMKK KDGNKDSNGA KKNLQFVGIN GGYETTSSDD SSSDESSSSE
1021 SDDECDVIEY PLEEEEEEED EDTRGMAEGH HAVNIEGLKS ARVEDEMQVQ ECEPEKVEIR
1081 ERYELSEKML SACNLLKNTI NDPKALTSKD MRFCLNTLQH EWFRVSSQKS AIPAMVGDYI
1141 AAFEAISPDV LRYVINLADG NGNTALHYSV SHSNFEIVKL LLDADVCNVD HQNKAGYTPI
1201 MLAALAAVEA EKDMRIVEEL FGCGDVNAKA SQAGQTALML AVSHGRIDMV KGLLACGADV
1261 NIQDDEGSTA LMCASEHGHV EIVKLLLAQP GCNGHLEDND GSTALSIALE AGHKDIAVLL
1321 YAHVNFAKAQ SPGTPRLGRK TSPGPTHRGS FDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KANK1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 81 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 81 nTPM
- liver: 60 nTPM
- heart muscle: 54 nTPM
- skeletal muscle: 44 nTPM
- urinary bladder: 39 nTPM
- choroid plexus: 39 nTPM
Single-cell type
- pituitary stem cells: 3,107 nCPM
- podocytes: 2,506 nCPM
- distal convoluted tubule cells: 1,881 nCPM
- choroid plexus epithelial cells: 1,718 nCPM
- cytotrophoblasts: 1,022 nCPM
- proximal tubule cells: 774 nCPM
Immune cell
- plasmacytoid DC: 3.5 nTPM
- naive CD4 T-cell: 1.9 nTPM
- memory CD4 T-cell: 1.1 nTPM
- T-reg: 1 nTPM
- naive B-cell: 0.8 nTPM
- memory B-cell: 0.6 nTPM
Brain region
- choroid plexus: 56 nTPM
- basal ganglia: 45 nTPM
- medulla oblongata: 45 nTPM
- thalamus: 39 nTPM
- spinal cord: 37 nTPM
- amygdala: 36 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KANK1.
Disease | AllUniProt
Conditions KANK1 is implicated in, by any mechanism.
- Cerebral palsy, spastic quadriplegic 2 (CPSQ2) MIM:612900
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 1,140 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cerebral palsy, spastic quadriplegic, 2
- Abnormal brain morphology
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- gnomAD missense Z
- -4.81
- DepMap mean gene effect
- 0.18
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- cell population proliferation
- cortical microtubule organization
- negative regulation of actin filament polymerization
- negative regulation of cell migration
- negative regulation of insulin receptor signaling pathway
- negative regulation of lamellipodium morphogenesis
- negative regulation of neuron projection development
- negative regulation of Rho protein signal transduction
- negative regulation of ruffle assembly
- negative regulation of substrate adhesion-dependent cell spreading
- podocyte cell migration
- positive regulation of canonical Wnt signaling pathway
- positive regulation of Wnt signaling pathway
- positive regulation of wound healing
- regulation of establishment of cell polarity
- regulation of Rho protein signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KANK1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KANK1 as an antibody target. Whether an autoantibody or antibody against KANK1 could matter depends on whether native KANK1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KANK1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KANK1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...